Fields to fermentors: Brewing botanical chemotherapeutic precursors using genetically engineered yeast
- PMID: 36370691
- DOI: 10.1016/j.medj.2022.10.006
Fields to fermentors: Brewing botanical chemotherapeutic precursors using genetically engineered yeast
Abstract
Plants are a rich source of chemotherapeutics and other essential medicines, but plant-based drug supply chains are unsustainable. Writing in Nature, Zhang et al.1 demonstrated a proof-of-concept alternate source of the anticancer drug vinblastine by engineering yeast to convert sugar and amino acids into its direct precursors, catharanthine and vindoline.
Copyright © 2022 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests C.D.S. is a founder and CEO of Antheia, Inc.
Comment on
-
A microbial supply chain for production of the anti-cancer drug vinblastine.Nature. 2022 Sep;609(7926):341-347. doi: 10.1038/s41586-022-05157-3. Epub 2022 Aug 31. Nature. 2022. PMID: 36045295 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
